Metabolic adaptability of E. coli: engineering autotrophic CO2 fixation

大肠杆菌的代谢适应性:工程自养二氧化碳固定

基本信息

  • 批准号:
    8311290
  • 负责人:
  • 金额:
    $ 4.92万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-05-01 至 2014-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The wealth of knowledge about central carbon metabolism has allowed organisms to be engineered for the production of useful molecules and has provided insight into many diseases, including obesity, diabetes, atherosclerosis, and some cancers (1, 2). Further advances in metabolic engineering have the potential to significantly impact both environmental protection and human health. For example, CO2 levels in the atmosphere are rising as human consumption of carbon-based fuels increases (3, 4), and the consequences on a 50-year timescale are expected to be dramatic. The goal of this proposal is to improve our understanding of central carbon metabolism by determining the changes needed to convert an organism from a heterotrophic to autotrophic mode of growth. Specifically, I propose to convert the well-characterized heterotrophic bacterium E. coli to an autotrophic mode of growth in which it fixes CO2 as its sole carbon source, using the Calvin cycle. This will involve introduction of foreign genes, targeted mutation of endogenous genes, quantitative modeling and measurement of metabolic fluxes, and directed evolution. The results will provide information about the regulation, evolution and plasticity of central carbon metabolism, and may enable new methods for carbon sequestration from the atmosphere. PUBLIC HEALTH RELEVANCE: Furthering our understanding of how the E. coli metabolic network can adapt to major changes will have at least a two-fold benefit. First, we hope to shed light on how bacterial metabolism can adapt to compensate for major changes to key steps of carbon utilization. Secondly, we hope to use this knowledge to drive the development of a rationally engineered strain of E. coli capable of surviving solely on carbon dioxide for the purpose of coupling atmospheric CO2 remediation with the production of molecules with medicinal or other useful properties.
描述(由申请人提供):关于中心碳代谢的丰富知识使得生物体能够被改造为生产有用的分子,并提供了对许多疾病的深入了解,包括肥胖、糖尿病、动脉粥样硬化和一些癌症 (1, 2)。代谢工程的进一步进步有可能对环境保护和人类健康产生重大影响。例如,随着人类碳基燃料消耗的增加,大气中的二氧化碳含量不断上升 (3, 4),预计 50 年的时间尺度上的后果将是巨大的。该提案的目标是通过确定生物体从异养生长模式转变为自养生长模式所需的变化来提高我们对中心碳代谢的理解。具体来说,我建议使用卡尔文循环将已充分表征的异养细菌大肠杆菌转变为自养生长模式,其中将二氧化碳固定为其唯一碳源。这将涉及外源基因的引入、内源基因的定向突变、代谢通量的定量建模和测量以及定向进化。研究结果将提供有关中心碳代谢的调节、演化和可塑性的信息,并可能为从大气中固碳提供新的方法。 公共卫生相关性:进一步了解大肠杆菌代谢网络如何适应重大变化将至少带来双重好处。首先,我们希望阐明细菌代谢如何适应以补偿碳利用关键步骤的重大变化。其次,我们希望利用这些知识来推动合理改造的大肠杆菌菌株的开发,该菌株能够仅靠二氧化碳生存,从而将大气二氧化碳修复与具有药用或其他有用特性的分子的生产结合起来。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wade M Hicks其他文献

Wade M Hicks的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wade M Hicks', 18)}}的其他基金

Metabolic adaptability of E. coli: engineering autotrophic CO2 fixation
大肠杆菌的代谢适应性:工程自养二氧化碳固定
  • 批准号:
    8458787
  • 财政年份:
    2012
  • 资助金额:
    $ 4.92万
  • 项目类别:

相似海外基金

Functional analysis of gp-340 involved in atherosclerosis caused by oral bacteria
gp-340参与口腔细菌引起动脉粥样硬化的功能分析
  • 批准号:
    18K09915
  • 财政年份:
    2018
  • 资助金额:
    $ 4.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of induction mechanism of atherosclerosis by oral biofilm bacteria-virulence caused by the mixture of diverse bacterial species
口腔生物膜细菌诱导动脉粥样硬化的机制分析——多种菌种混合引起的毒力
  • 批准号:
    17K12015
  • 财政年份:
    2017
  • 资助金额:
    $ 4.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Involvement of innate immune factor gp-340 in atherosclerosis caused by oral bacteria
先天免疫因子gp-340参与口腔细菌引起的动脉粥样硬化
  • 批准号:
    26463166
  • 财政年份:
    2014
  • 资助金额:
    $ 4.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of relationship between intestinal dysbiosis by periodontopathic bacteria and atherosclerosis
牙周病菌肠道菌群失调与动脉粥样硬化的关系分析
  • 批准号:
    26893086
  • 财政年份:
    2014
  • 资助金额:
    $ 4.92万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Experimental analysis of induction mechanism of atherosclerosis by human oral bacteria
人体口腔细菌诱导动脉粥样硬化机制的实验分析
  • 批准号:
    26463168
  • 财政年份:
    2014
  • 资助金额:
    $ 4.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The association between atherosclerosis and Aa that is a periodontal pathogenic bacteria.
动脉粥样硬化与牙周病原菌 Aa 之间的关联。
  • 批准号:
    26861821
  • 财政年份:
    2014
  • 资助金额:
    $ 4.92万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Augmentative effect of high glucose on atherosclerosis due to periodontal bacteria-derived lipopolysaccaride
高葡萄糖对牙周细菌来源的脂多糖引起的动脉粥样硬化的增强作用
  • 批准号:
    25463222
  • 财政年份:
    2013
  • 资助金额:
    $ 4.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Experimental analysis of the induction mechanism of atherosclerosis by oral biofilm bacteria as a possible new risk factor
口腔生物膜细菌作为可能的新危险因素诱导动脉粥样硬化机制的实验分析
  • 批准号:
    20592459
  • 财政年份:
    2008
  • 资助金额:
    $ 4.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Acceleration of atherosclerosis by periodontopathic bacteria and development of preventive vaccine
牙周病细菌加速动脉粥样硬化和预防性疫苗的开发
  • 批准号:
    19390537
  • 财政年份:
    2007
  • 资助金额:
    $ 4.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Is NADPH oxidase the trigger for accelerated atherosclerosis caused by bacteria?
NADPH氧化酶是细菌引起的加速动脉粥样硬化的触发因素吗?
  • 批准号:
    nhmrc : 436825
  • 财政年份:
    2007
  • 资助金额:
    $ 4.92万
  • 项目类别:
    NHMRC Project Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了